Building bridges
Building bridges
AllerGen engaging in partnering strategy
In its bid to create an atmosphere of knowledge sharing that impacts the lives of Canadians in a positive way, AllerGen is forging new national and global partnerships.
As a member of the Networks of Centres of Excellence (NCE) Canada program, AllerGen must focus on developing new knowledge and transmitting that knowledge to those who can generate new products and services to positively impact Canadians suffering from allergic disease.
To that end, AllerGen is actively engaged at both the individual research project and Network-wide levels, initiating and fostering new relationships to expand the reach of the Network.
Joining forces with the Asthma Society of Canada
AllerGen is partnering with the Asthma Society of Canada (ASC), taking an active role in an initiative that aims to improve the quality of life for Canadians suffering from allergy, asthma, and chronic obstructive pulmonary disease (COPD).
AllerGen Scientific Director Dr. Judah Denburg has engaged in preliminary meetings with representatives from the ASC to discuss a collaboration focussed on the creation of a national strategy to control these chronic diseases.
Dr. Oxana Latycheva, ASC vice-president of Asthma Control Programming, believes this collaboration could be "one of the strongest partnerships in terms of the longterm benefits for patients suffering from asthma and allergies."
She believes that AllerGen's status as a leader in the field of allergic disease will aid the ASC in realizing its goal to improve the lives of those suffering from allergic disease, asthma and COPD.
"The ASC is delighted to partner with AllerGen on many initiatives aimed to improve care for patients with asthma and allergies and making sure that Canadians suffering with asthma and allergies get the care they need and deserve," she says.